Tuberculosis: all 1,435 studies
Page 8 of 15. Open to participants first (208), then studies with results posted, then the rest; newest registration first within each.
- Micro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected PatientsStatus unknownNCT03941210
- Assessing the Ability of the T-SPOT®.TB TestCompletedNCT03929705
- Clinico-radiological Classification of Peritoneal TuberculosisCompletedNCT03927664
- Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBMCompletedNCT03927313Phase 2
- Pharmacokinetics of Atazanavir in Special PopulationsCompletedNCT03923231
- Immunomodulatory Vitamin D in ThalassemiaCompletedNCT03919812Not applicable
- Acute Presentation and Management of Abdominal Tuberculosis: A Ten-year Experience at a Tertiary Care Center in PakistanCompletedNCT03918226Not applicable
- Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe PneumoniaCompletedNCT03915366Phase 2/3
- Investigating Immune Responses to Aerosol BCG Challenge in Healthy UK AdultsActive, not recruitingNCT03912207Phase 1
- Prevalence of Latent Tuberculosis in High Risk ChildrenStatus unknownNCT03910946
- Short Course Rifapentine and Isoniazid for the Preventive Treatment of Tuberculosis(SCRIPT-TB)Status unknownNCT03900858Not applicable
- Retrospective Real-word Study of Linezolid for the Treatment of Tuberculous MeningitisStatus unknownNCT03898635
- Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)CompletedNCT03896685Phase 3
- Patient Centered Intervention to Prevent Tuberculosis Among Children Under Five Years OldCompletedNCT03881228Not applicable
- Phase II Clinical Trial of Safety and Immunogenicity of Recombinant Subunit Tuberculosis Vaccine GamTBvacCompletedNCT03878004Phase 2
- Evaluation of an Infant Immunization Encouragement Program in NigeriaCompletedNCT03870061Not applicable
- Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)CompletedNCT03867136Phase 4
- Integrating Pediatric TB Services Into Child Healthcare Services in AfricaCompletedNCT03862261Not applicable
- Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating MoreWithdrawnNCT03862248Phase 3
- Nyaditum Resae® as a Co-adjuvant During Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut MicrobiotaActive, not recruitingNCT03851159Not applicable
- Community-based Tuberculosis Tracing and Preventive TherapyCompletedNCT03832023Not applicable
- Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia)CompletedNCT03831906Not applicable
- The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TBCompletedNCT03830671Phase 4
- Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB TuberculosisStatus unknownNCT03827811
- Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH CohortCompletedNCT03822156
- Respiratory Function in Patients With Post-tuberculosis Lung ImpairmentStatus unknownNCT03821285Not applicable
- Improving HIV/Tuberculosis Outcomes in IrkutskCompletedNCT03819374
- Innovative Reagents for Improving Rapid Diagnosis of Mycobacterial InfectionsStatus unknownNCT03808636
- Digital Health Promotion in Iringa, TanzaniaCompletedNCT03808597Not applicable
- Phase 1 Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy AdolescentStatus unknownNCT03806699Phase 1
- Phase 2a Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Healthcare WorkersStatus unknownNCT03806686Phase 2
- Thin Bronchoscope and Virtual Bronchoscopic Navigation System for TuberculosisCompletedNCT03802812Not applicable
- Real-time Tuberculosis Medication Adherence Intervention in Rural Southwestern UgandaStatus unknownNCT03800888Not applicable
- Contributing Factors for Poor HIV Treatment Response in Children With TB/HIV CoinfectionCompletedNCT03800407
- Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected AdolescentsCompletedNCT03800394
- Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) TabletCompletedNCT03800381
- Multiplex PCR -Microarray-based Assay in the Detection of MycobacteriumCompletedNCT03794284
- Optimizing Antituberculosis Therapy in Adults With Tuberculous MeningitisStatus unknownNCT03787940Not applicable
- Effect of Community Mobile Outreach Approach Compared to Facility Based Directly Observed Treatment Short Course on Treatment Outcome Among Tuberculosis Patients in Jeddah: A Randomized Controlled TrialCompletedNCT03787914Not applicable
- Video Based Directly Observed Therapy for Latent TBWithdrawnNCT03783728
- Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PBTZ169 in Multiple DosingCompletedNCT03776500Phase 1
- Epidemiological Study In Tuberculosis-Endemic Urban Area in SenegalCompletedNCT03767946
- TB Reduction Through ART and TB Screening ProjectStatus unknownNCT03739736
- Characteristics of Tuberculosis Infection in Rheumatic DiseaseCompletedNCT03736278
- Rapid and Accurate Diagnosis of Paediatric TB (RaPaed-AIDA-TB)CompletedNCT03734172
- PREVAIL VIII: A CoHOrt Clinical, Viral, and ImmuNOlogic Monitoring Study of People Living With Retroviral Infection in Liberia (HONOR)CompletedNCT03733093
- Bronchial Washings in Sputum Scarce Cases of Pulmonary TuberculosisWithdrawnNCT03732014
- Xpert MTB/XDR Clinical Evaluation TrialCompletedNCT03728725
- Clinical Evaluation of the Truenat Point-of-care Tuberculosis Diagnostic TestCompletedNCT03712709
- Nutritional Support for HIV-Tuberculosis Co-infected Adults in Senegal, West AfricaCompletedNCT03711721Not applicable
- Adjunctive NAC in Adult Patients With Pulmonary TuberculosisCompletedNCT03702738Phase 2
- Diagnosing of Acute TuberculosisCompletedNCT03667742
- A Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism StatusCompletedNCT03665402Not applicable
- Tuberculosis Diagnosis by Flow CytometryWithdrawnNCT03639038
- NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TBStatus unknownNCT03604848Not applicable
- Tuberculosis - Learning the Impact of NutritionCompletedNCT03598842Not applicable
- A Single Ascending Dose Study of BTZ043CompletedNCT03590600Phase 1
- Clinical Study on Adoptive Treatment of MDR-TB With Allogeneic γδT CellsStatus unknownNCT03575299Phase 1
- Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis PatientsActive, not recruitingNCT03568383Phase 3
- Pilot Clinical Trial of PRS TB Regimen I - Phase IICompletedNCT03561753Phase 4
- Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)CompletedNCT03559582
- Clinical Research on Comprehensive Treatment of Tuberculosis With Malignant Solid TumorCompletedNCT03551795Phase 1/2
- VDOT and Mobile Payments in CambodiaWithdrawnNCT03547479Not applicable
- Accuracy and Consequences of Using Trial-of-antibiotics for TB Diagnosis (ACT-TB Study)CompletedNCT03545373Phase 3
- Pharmacokinetic Study of Linezolid for TB MeningitisCompletedNCT03537495Phase 2
- Dietary Assessment and Prevalence of Refeeding Syndrome in High-risk TB Patients in Chhattisgarh, IndiaCompletedNCT03537170
- Dose-Defining Safety and Immunogenicity Study of MTBVAC in South African NeonatesCompletedNCT03536117Phase 2
- A Pragmatic Randomised Study to Optimise Screening, Prevention and Care for Tuberculosis in MalawiStatus unknownNCT03519425Not applicable
- A Multidrug-resistant (MDR) and Extensively Drug- Resistant (XDR) Tuberculosis Study in AlsaceStatus unknownNCT03507816
- Evaluation of Diabetes Control and Effect on Transmission and Development of TuberculosisWithdrawnNCT03498534Phase 4
- Achieving Tuberculosis (TB) Control In ZambiaCompletedNCT03497195Not applicable
- Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With TuberculosisStatus unknownNCT03478033Not applicable
- Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive TuberculosisCompletedNCT03474198Phase 2/3
- Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TBCompletedNCT03470233
- Cohort Study on People Who Inject Drugs in SenegalStatus unknownNCT03459768
- Prevalence of Chronic Kidney Disease (CKD) and Risk Factors in Sub-Saharan AfricaCompletedNCT03458338
- Development of a Rapid and Accurate Diagnostic Assay for TuberculosisStatus unknownNCT03423550
- Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Ex-vivo Antitubercular Activity of PBTZ169 FormulationCompletedNCT03423030Phase 1
- Personalization of AntiTB Treatment: Evaluation of Pharmacological Determinants of Treatment ResponseStatus unknownNCT03416309
- Feasibility of Centralized Therapeutic Drug Monitoring of Fluoroquinolones in Multi-Drug Resistant Tuberculosis PatientsStatus unknownNCT03409315
- Immune Response to BCG Vaccination in Neonates Born to HIV and LTBI Infected and Non-infected MothersCompletedNCT03383211
- Study to Investigate the Safety and Efficacy of GC3107 (BCG Vaccine) in Healthy AdultsStatus unknownNCT03363178Phase 1
- Improving TB Diagnosis and Treatment Through Basic, Applied and Health Systems ResearchCompletedNCT03356925Not applicable
- Evaluation of Host Biomarker-based Point-of-care Tests for Targeted Screening for Active TBCompletedNCT03350048
- Immunologic Markers for the Differential Diagnosis Between Uveitis-TBC and Uveitis-SARC (TBC-SARC)CompletedNCT03346018
- Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in PakistanStatus unknownNCT03341195Not applicable
- Adverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis InfectionStatus unknownNCT03312647
- Tuberculosis Infection in Women of Reproductive Age and Their InfantsCompletedNCT03305991
- DIAgnostics for Multidrug Resistant Tuberculosis in AfricaCompletedNCT03303963
- Treating Tuberculosis Wasting With a High-protein SupplementTerminatedNCT03302949Not applicable
- RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/TB Co-infectionStatus unknownNCT03281226Phase 2
- Joint Management of DM2 and Pulmonary TB in Orizaba, VeracruzWithdrawnNCT03277742Not applicable
- Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized PatientsCompletedNCT03271567
- Treatment of Latent Tuberculosis in Socially Marginalised CitizensTerminatedNCT03266991Phase 4
- A Phase II Study of H56:IC31 in Healthy AdolescentsWithdrawnNCT03265977Phase 2
- Expand New Drugs for TB [endTB]CompletedNCT03259269
- Evaluation of the Safety and Immunogenicity of the Recombinant Subunit Vaccine "GamTBvac" Against the Tuberculosis.CompletedNCT03255278Phase 1
- TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TBStatus unknownNCT03251196
- The Individualized M(X) Drug-resistant TB Treatment Strategy StudyTerminatedNCT03237182Phase 4
- Impact of Nursing Interventions on Adherence to Treatment With Anti-tuberculosis Drugs in Children and AdolescentsCompletedNCT03230409Not applicable